Last deal

Amount

Series B

Stage

14.05.2024

Date

4

all rounds

$27.9M

Total amount

General

About Company
IICE Bioscience is an Innovative CRO+ Explorer company specializing in early drug discovery services.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Contract Research Organization, CRO

founded date

18.06.2010

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

With a focus on Immunology, Oncology, Cardiovascular, and CNS diseases, IICE Bioscience offers target validation, assay development, and pre-clinical candidate identification. They have a wide range of ready-to-use screening platforms and a track record of successful collaborations with over 600 clients.
Contacts

Phone number

Social url